Table 2.
Sleep Apnea Symptoms in Surgery and Control Groups
Surgery | Control | P-value | OR (95% CI) | |
---|---|---|---|---|
Number of subjects | 1592 | 1431 | ||
Freq. apneas | ||||
Baseline, % | 24.0 | 21.8 | <0.001 | |
Follow-up, % | 8.3 | 20.8 | <0.001 | |
Incidence, % | 2.3 | 6.7 | <0.001 | 0.28 (0.16 to 0.49) |
Persistence, % | 27.9 | 71.3 | <0.001 | 0.16 (0.10 to 0.23) |
Freq. snoring | ||||
Baseline, % | 44.5 | 35.6 | <0.001 | |
Follow-up, % | 10.8 | 29.8 | <0.001 | |
Incidence, % | 2.1 | 10.0 | <0.001 | 0.18 (0.10 to 0.32) |
Persistence, % | 21.6 | 65.5 | <0.001 | 0.14 (0.10 to 0.19) |
Freq. daytime sleepiness | ||||
Baseline, % | 25.8 | 20.4 | <0.001 | |
Follow-up, % | 12.7 | 17.8 | <0.001 | |
Incidence, % | 5.9 | 8.4 | 0.018 | 0.66 (0.45 to 0.96) |
Persistence, % | 32.6 | 54.6 | <0.001 | 0.44 (0.30 to 0.63) |
Incidence: proportion of subjects with symptoms at 2-year among those without reported symptoms at baseline
Persistence: proportion of subjects with symptoms at 2-year among those with reported symptoms at baseline
Proportions are unadjusted values. P-value: Fischer's exact test, unadjusted
OR (95% CI): odds-ratio (95% confidence interval), adjusted for age, sex, BMI, smoking, diabetes, alcohol, and neck circumference at baseline